Applied Molecular Transport to Present at Virtual Jefferies London Healthcare Conference

November 15, 2021 at 8:01 AM EST

SOUTH SAN FRANCISCO, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Bittoo Kanwar, M.D., chief medical officer, and Liz Bhatt, chief business and strategy officer, will participate in a fireside chat during the Virtual Jefferies London Healthcare Conference on Thursday, November 18, 2021 at 8:00 a.m. GMT.

To access the archived recording of the fireside chat, please visit the Events page of the Applied Molecular Transport website at The archived replay will be available for 30 days following the event.

About Applied Molecular Transport Inc.
Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. AMT’s proprietary technology platform allows it to exploit existing natural cellular trafficking pathways to facilitate the active transport of diverse therapeutic modalities across the intestinal epithelial (IE) barrier. Active transport is an efficient mechanism that uses the cell’s own machinery to transport materials across the IE barrier. AMT believes that its ability to exploit this mechanism is a key differentiator of its approach. AMT is developing additional oral biologic product candidates in patient-friendly oral forms that are designed to either target local gastrointestinal tissue or enter systemic circulation to precisely address the relevant biology of a disease.

AMT’s headquarters, internal GMP manufacturing and lab facilities are located in South San Francisco, CA. For additional information on AMT, please visit

Investor Relations Contact:
Andrew Chang
Head, Investor Relations & Corporate Communications

Media Contacts:
Alexandra Santos
Wheelhouse Life Science Advisors

Aljanae Reynolds
Wheelhouse Life Science Advisors